Accepted: 11 October 2020
First Online: 4 January 2021
: M.L.M. has been compensated for consulting, speaking fees or service on advisory boards for the Kerry Health and Nutrition Institute and the Icelandic Milk & Skyr Corporation. M.E.S. has been compensated for funding or speaking engagements or for consulting from Associated British Foods, California Dairy Research Foundation, Cargill, Danone Research, Danone USA, Fairlife, General Mills, GlaxoSmithKline, JJ Heimbach, Kellogg, Kerry, Mead Johnson, Medscape, PepsiCo, Pfizer, Probi, Procter & Gamble, Trouw Nutrition, Visalia Dairy Company, Winclove Probiotics and Yakult. P.D.C. has research grants with several industry partners and is the co-founder and Chief Technology Officer of SeqBiome. C.H. serves on the board of International Scientific Association for Probiotics and Prebiotics (ISAPP), is a consultant to Artugen Therapeutics developing a live biotherapeutic and has research grants with several industry partners. W.H. has been compensated for consulting by SymbioPharm, received research grants from industry partners and is co-founder and Chief Technology Officer of HEM. S.L. serves on the board of ISAPP, is chair of the Scientific Advisory Board of Yun, has been compensated for speaking by Yakult and has research grants with several industry partners. D.M. serves on the board of ISAPP and has consulted for Bayer, Pharmavite and Dupont. G.R. serves on the board of ISAPP and has received fees from Seed, Danone, Acerus Pharma and KGK Science. R.H. serves on the board of ISAPP, has received grants or honoraria from Mead Johnson Nutrition, Pharmavite, Danone, Beachbody and PepsiCo, and is a co-owner of Synbiotic Health. M.G.G., M.C.A., L.D.V. and B.E.W. declare no competing interests.